Michael Aronstein - 31 Dec 2021 Form 5 Insider Report for AngioGenex, Inc.

Reporting relationship: Director, CHAIRMAN, 10%+ Owner
Issuer ticker: N/A
Reported as of: 31 Dec 2021
Net transaction value: +$134,362,775,000
SEC form: 5
Accepted by SEC: 15 Feb 2022, 15:41:38 UTC
Source filing: View source filing
Reporting owner signature: /s/ MICHAEL ARONSTEIN

Key filing fact

Michael Aronstein filed Form 5 for AngioGenex, Inc. on 15 Feb 2022.

Key facts

This page summarizes Michael Aronstein's Form 5 filing for AngioGenex, Inc..
11 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 15 Feb 2022, 15:41.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$134,362,775,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGGX transaction

Common Stock

Award

Transaction value: $6,250,000,000
Shares: +250,000
Change %: +4.3%
Price: $25000.00^*
Shares after: 6,000,000
Date: 23 Oct 2019
Ownership: Direct

AGGX transaction

Common Stock

Award

Transaction value: $6,250,000,000
Shares: +250,000
Change %: +4.3%
Price: $25000.00^*
Shares after: 6,000,000
Date: 30 Dec 2019
Ownership: Direct

AGGX transaction

Common Stock

Award

Transaction value: $125,000,000
Shares: +25,000
Change %: +0.41%
Price: $5000.00^*
Shares after: 6,130,555
Date: 03 Mar 2020
Ownership: Direct

AGGX transaction

Common Stock

Award

Transaction value: $500,000,000
Shares: +50,000
Change %: +0.82%
Price: $10000.00^*
Shares after: 6,130,555
Date: 05 Aug 2020
Ownership: Direct

AGGX transaction

Common Stock

Award

Transaction value: $555,550,000
Shares: +55,555
Change %: +0.91%
Price: $10000.00^*
Shares after: 6,130,555
Date: 08 Oct 2020
Ownership: Direct

AGGX transaction

Common Stock

Award

Transaction value: $40,000,000,000
Shares: +400,000
Change %: +5.6%
Price: $100000.00^*
Shares after: 7,507,827
Date: 02 Mar 2021
Ownership: Direct

AGGX transaction

Common Stock

Award

Transaction value: $5,681,800,000
Shares: +227,272
Change %: +3.1%
Price: $25000.00^*
Shares after: 7,507,827
Date: 08 Jun 2021
Ownership: Direct

AGGX transaction

Common Stock

Award

Transaction value: $75,000,000,000
Shares: +750,000
Change %: +11%
Price: $100000.00^*
Shares after: 7,507,827
Date: 31 Aug 2021
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGGX transaction Derivative

Stock Option

Award

Transaction value: $105,000
Shares: +3,000,000
Change %
Price: $0.0350^*
Shares after: 3,000,000
Date: 15 Jan 2019
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,000,000
Exercise price: $0.3500

AGGX transaction Derivative

Stock Option

Award

Transaction value: $260,000
Shares: +2,000,000
Change %: +67%
Price: $0.1300^*
Shares after: 5,000,000
Date: 02 Sep 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,000,000
Exercise price: $0.1300

AGGX transaction Derivative

Convertible Note

Award

Transaction value: $60,000
Shares: +240,000
Change %: +4.8%
Price: $0.2500^*
Shares after: 5,240,000
Date: 02 Nov 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 240,000
Exercise price: $25.00

^* marks a reported price that did not pass the local price check.